Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pantoprazole in Children Ages 1 to 5 With GERD
NCT00300755Phase 3Completed
- Sponsor
- Pfizer
- Start
- May 2006
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial of pantoprazole in gastroesophageal reflux disease (GERD) (3 arms), sponsored by Pfizer. Primary endpoint: Change in Weekly Gastroesophageal Reflux Disease (GERD) Symptom Scores. Started May 2006; status: completed.
02
Drugs
pantoprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT00300755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00300755.